Intratibial injection of patient‑derived tumor cells from giant cell tumor of bone elicits osteolytic reaction in nude mouse

Xu,Leqin; Wu,Zhipeng; Zhou,Zhenhua; Yang,Xinghai; Xiao,Jianru

doi:10.3892/ol.2018.9148

Intratibial injection of patient‑derived tumor cells from giant cell tumor of bone elicits osteolytic reaction in nude mouse

Authors:
- Leqin Xu
- Zhipeng Wu
- Zhenhua Zhou
- Xinghai Yang
- Jianru Xiao
View Affiliations

Affiliations: Department of Orthopedic Oncology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China
Published online on: July 16, 2018 https://doi.org/10.3892/ol.2018.9148
Pages: 4649-4655

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

There have been various reports in the literature of an in vivo model for giant cell tumor of bone (GCTB). However, few suitable animal models of GCTB have been established, due to the fact that GCTB contains three histologically different cell types. To the best of our knowledge, injection of patient‑derived GCTB cells into bone environment has not been reported until now. In the present study, the biological behavior of GCTB cells in nude mice was investigated through intratibial injection of patient‑derived GCTB cells. Patient‑derived GCTB cells were obtained from 5 patients who had not undergone chemo‑ and radiotherapy. Once isolated, the cell suspension was injected into the tibias of nude mice. The growth process was monitored by weekly observation and photographic documentation using X‑ray. Four months after injection, nude mice were sacrificed and the injected tibial samples were fixed, and further analyzed using micro‑computed tomography (micro‑CT), standard histology, tartrate‑resistant acid phosphatase (TRAP) staining and mitochondrial immunofluorescence staining. X‑ray, micro‑CT and standard histology revealed osteolytic destruction in the proximal end of the tibia. TRAP staining identified TRAP‑positive, osteoclast‑like cells distributed in the bone marrow interface of the lesion area. Anti‑human mitochondrial immunofluorescence staining confirmed that the surviving cells in the osteolytic destruction were of human GCTB cell origin. These findings indicate that intratibial injection of patient‑derived GCTB cells may elicit osteolytic destruction in nude mice. The results of the current study present a novel animal model for GCTB, opening new perspectives to investigate this disease and develop therapeutic agents.

View Figures

View References

1	Cowan RW and Singh G: Giant cell tumor of bone: A basic science perspective. Bone. 52:238–246. 2013. View Article : Google Scholar : PubMed/NCBI
2	Alsulaimani SA and Turcotte RE; Canadian Orthopaedic Oncology Society (CANOOS) collaborators, : Iterative curettage is associated with local control in giant cell tumors involving the distal tibia. Clin Orthop Relat Res. 471:2668–2674. 2013. View Article : Google Scholar : PubMed/NCBI
3	Stacy GS, Peabody TD and Dixon LB: Mimics on radiography of giant cell tumor of bone. AJR Am J Roentgenol. 181:1583–1589. 2003. View Article : Google Scholar : PubMed/NCBI
4	Prosser GH, Baloch KG, Tillman RM, Carter SR and Grimer RJ: Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone? Clin Orthop Relat Res. 435:211–218. 2005. View Article : Google Scholar
5	Kremen TJ Jr, Bernthal NM, Eckardt MA and Eckardt JJ: Giant cell tumor of bone: Are we stratifying results appropriately? Clin Orthop Relat Res. 470:677–683. 2012. View Article : Google Scholar : PubMed/NCBI
6	Lin WH, Lan TY, Chen CY, Wu K and Yang RS: Similar local control between phenol- and ethanol-treated giant cell tumors of bone. Clin Orthop Relat Res. 469:3200–3208. 2011. View Article : Google Scholar : PubMed/NCBI
7	Klenke FM, Wenger DE, Inwards CY, Rose PS and Sim FH: Recurrent giant cell tumor of long bones: Analysis of surgical management. Clin Orthop Relat Res. 469:1181–1187. 2011. View Article : Google Scholar : PubMed/NCBI
8	Klenke FM, Wenger DE, Inwards CY, Rose PS and Sim FH: Giant cell tumor of bone: Risk factors for recurrence. Clin Orthop Relat Res. 469:591–599. 2011. View Article : Google Scholar : PubMed/NCBI
9	Goldring SR, Schiller AL, Mankin HJ, Dayer JM and Krane SM: Characterization of cells from human giant cell tumors of bone. Clin Orthop Relat Res. 1–75. 1986.
10	Komiya S, Sasaguri Y, Inoue A, Nakashima M, Yamamoto S, Yanagida I and Morimatsu M: Characterization of cells cultured from human giant-cell tumors of bone. Phenotypic relationship to the monocyte-macrophage and osteoclast. Clin Orthop Relat Res. 258:304–309. 1990.
11	Salerno M, Avnet S, Alberghini M, Giunti A and Baldini N: Histogenetic characterization of giant cell tumor of bone. Clin Orthop Relat Res. 466:2081–2091. 2008. View Article : Google Scholar : PubMed/NCBI
12	Wülling M, Delling G and Kaiser E: The origin of the neoplastic stromal cell in giant cell tumor of bone. Hum Pathol. 34:983–993. 2003. View Article : Google Scholar : PubMed/NCBI
13	Lau CP, Ng PK, Li MS, Tsui SK, Huang L and Kumta SM: p63 regulates cell proliferation and cell cycle progressionassociated genes in stromal cells of giant cell tumor of the bone. Int J Oncol. 42:437–443. 2013. View Article : Google Scholar : PubMed/NCBI
14	Wuelling M, Delling G and Kaiser E: Differential gene expression in stromal cells of human giant cell tumor of bone. Virchows Arch. 445:621–630. 2004. View Article : Google Scholar : PubMed/NCBI
15	Babeto E, Conceição AL, Valsechi MC, Peitl Junior P, de Campos Zuccari DA, de Lima LG, Bonilha JL, de Freitas Calmon M, Cordeiro JA and Rahal P: Differentially expressed genes in giant cell tumor of bone. Virchows Arch. 458:467–476. 2011. View Article : Google Scholar : PubMed/NCBI
16	Chen S, Li C, Wu B, Zhang C, Liu C, Lin X, Wu X, Sun L, Liu C, Chen B, et al: Identification of differentially expressed genes and their subpathways in recurrent versus primary bone giant cell tumors. Int J Oncol. 45:1133–1142. 2014. View Article : Google Scholar : PubMed/NCBI
17	Fujikawa Y, Quinn JM, Sabokbar A, McGee JO and Athanasou NA: The human osteoclast precursor circulates in the monocyte fraction. Endocrinology. 137:4058–4060. 1996. View Article : Google Scholar : PubMed/NCBI
18	Massey HM and Flanagan AM: Human osteoclasts derive from CD14-positive monocytes. Br J Haematol. 106:167–170. 1999. View Article : Google Scholar : PubMed/NCBI
19	Lau YS, Sabokbar A, Gibbons CL, Giele H and Athanasou N: Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Hum Pathol. 36:945–954. 2005. View Article : Google Scholar : PubMed/NCBI
20	Haque AU and Moatasim A: Giant cell tumor of bone: A neoplasm or a reactive condition? Int J Clin Exp Pathol. 1:489–501. 2008.PubMed/NCBI
21	Werner M: Giant cell tumour of bone: Morphological, biological and histogenetical aspects. Int Orthop. 30:484–489. 2006. View Article : Google Scholar : PubMed/NCBI
22	James IE, Dodds RA, Olivera DL, Nuttall ME and Gowen M: Human osteoclastoma-derived stromal cells: Correlation of the ability to form mineralized nodules in vitro with formation of bone in vivo. J Bone Miner Res. 11:1453–1460. 1996. View Article : Google Scholar : PubMed/NCBI
23	Balke M, Neumann A, Szuhai K, Agelopoulos K, August C, Gosheger G, Hogendoorn PC, Athanasou N, Buerger H and Hagedorn M: A short-term in vivo model for giant cell tumor of bone. BMC Cancer. 11:2412011. View Article : Google Scholar : PubMed/NCBI
24	Singh S, Singh M, Mak I and Ghert M: Expressional analysis of GFP-tagged cells in an in vivo mouse model of giant cell tumor of bone. Open Orthop J. 7:109–113. 2013. View Article : Google Scholar : PubMed/NCBI
25	Oreffo RO, Marshall GJ, Kirchen M, Garcia C, Gallwitz WE, Chavez J, Mundy GR and Bonewald LF: Characterization of a cell line derived from a human giant cell tumor that stimulates osteoclastic bone resorption. Clin Orthop Relat Res. 229–241. 1993.PubMed/NCBI
26	Long F, Cai X, Luo W, Chen L and Li K: Role of aldolase A in osteosarcoma progression and metastasis: In vitro and in vivo evidence. Oncol Rep. 32:2031–2037. 2014. View Article : Google Scholar : PubMed/NCBI
27	Park SI, Kim SJ, McCauley LK and Gallick GE: Pre-clinical mouse models of human prostate cancer and their utility in drug discovery. Curr Protoc Pharmacol Chapter. 14:Unit 14.15. 2010. View Article : Google Scholar
28	Hoff BA, Chughtai K, Jeon YH, Kozloff K, Galbán S, Rehemtulla A, Ross BD and Galbán CJ: Multimodality imaging of tumor and bone response in a mouse model of bony metastasis. Transl Oncol. 5:415–421. 2012. View Article : Google Scholar : PubMed/NCBI
29	Futakuchi M and Singh RK: Animal model for mammary tumor growth in the bone microenvironment. Breast Cancer (Tokyo, Japan). 20:195–203. 2013. View Article : Google Scholar : PubMed/NCBI
30	Balla P, Moskovszky L, Sapi Z, Forsyth R, Knowles H, Athanasou NA, Szendroi M, Kopper L, Rajnai H, Pinter F, et al: Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone. Histopathology. 59:376–389. 2011. View Article : Google Scholar : PubMed/NCBI
31	National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals: Guide for the Care and Use of Laboratory Animals. 8th edition. National Academies Press; Washington, DC: 2011
32	Tang X, Jin R, Qu G, Wang X, Li Z, Yuan Z, Zhao C, Siwko S, Shi T, Wang P, et al: GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway. Cancer Res. 73:6206–6218. 2013. View Article : Google Scholar : PubMed/NCBI
33	Huang L, Teng XY, Cheng YY, Lee KM and Kumta SM: Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone. Bone. 34:393–401. 2004. View Article : Google Scholar : PubMed/NCBI
34	Murata A, Fujita T, Kawahara N, Tsuchiya H and Tomita K: Osteoblast lineage properties in giant cell tumors of bone. J Orthop Sci. 10:581–588. 2005. View Article : Google Scholar : PubMed/NCBI
35	Ghert M, Simunovic N, Cowan RW, Colterjohn N and Singh G: Properties of the stromal cell in giant cell tumor of bone. Clin Orthop Relat Res. 459:8–13. 2007. View Article : Google Scholar : PubMed/NCBI
36	Yang T, Zheng XF, Li M, Lin X and Yin QS: Stimulation of osteogenic differentiation in stromal cells of giant cell tumour of bone by zoledronic acid. Asian Pac J Cancer Prev. 14:5379–5383. 2013. View Article : Google Scholar : PubMed/NCBI
37	McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I and Overall CM: Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem. 276:43503–43508. 2001. View Article : Google Scholar : PubMed/NCBI
38	Atkins GJ, Haynes DR, Graves SE, Evdokiou A, Hay S, Bouralexis S and Findlay DM: Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. J Bone Miner Res. 15:640–649. 2000. View Article : Google Scholar : PubMed/NCBI
39	McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I and Overall CM: Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood. 100:1160–1167. 2002.PubMed/NCBI
40	Ohsaki Y, Takahashi S, Scarcez T, Demulder A, Nishihara T, Williams R and Roodman GD: Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone. Endocrinology. 131:2229–2234. 1992. View Article : Google Scholar : PubMed/NCBI
41	Sasaguri Y, Komiya S, Sugama K, Suzuki K, Inoue A, Morimatsu M and Nagase H: Production of matrix metalloproteinases 2 and 3 (stromelysin) by stromal cells of giant cell tumor of bone. Am J Pathol. 141:611–621. 1992.PubMed/NCBI
42	Ueda Y, Imai K, Tsuchiya H, Fujimoto N, Nakanishi I, Katsuda S, Seiki M and Okada Y: Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. Am J Pathol. 148:611–622. 1996.PubMed/NCBI
43	Cowan RW, Singh G and Ghert M: PTHrP increases RANKL expression by stromal cells from giant cell tumor of bone. J Orthop Res. 30:877–884. 2012. View Article : Google Scholar : PubMed/NCBI
44	Morgan T, Atkins GJ, Trivett MK, Johnson SA, Kansara M, Schlicht SL, Slavin JL, Simmons P, Dickinson I, Powell G, et al: Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB. Am J Pathol. 167:117–128. 2005. View Article : Google Scholar : PubMed/NCBI